OPTN - オプティノ―ズ （OptiNose Inc.） オプティノ―ズOPTNのチャート
OPTNの企業情報
| symbol | OPTN |
|---|---|
| 会社名 | OptiNose Inc （オプティノ―ズ） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Major Pharmaceuticals |
| 業種 | バイオテクノロジ―_メディカルリサ―チ 医療関連（Health Care） |
| 概要 | 事業概要 オプティノーズ(OptiNose Inc.)は製薬会社である。同社は、耳、鼻、咽喉、またはENT、及びアレルギーの専門家によって治療された患者のための製品の開発・商品化に従事する。同社の製品候補には、XHANCE（鼻ポリープ）、チャンス（慢性副鼻腔炎）OPN-300、OPN-021などがある。主力製品であるXHANCE（プロピオン酸フルチカゾン）の鼻スプレーは、鼻ポリープを伴う慢性鼻副鼻腔炎の治療用局所的に作用し強力な抗炎症性コルチコステロイドを送達するために、呼吸動力呼気供給システム（EDS）を利用する。XHANCEは、炎症の原発部位に薬物を送達することができるため、この疾患の治療基準の一部となる可能性を有する差別化された臨床プロファイルを有する。 オプティノ―ズは米国の専門医薬品企業。主に耳鼻咽喉科の疾患に対する治療薬の開発・商業化に従事する。同社製品には鼻ポリ―プの有無に関わらず慢性鼻副鼻腔炎の治療用に、局所作用の抗炎症性コルチコステロイドを送達する呼気供給システムの「XHANCE」を含む。また、偏頭痛の治療薬「AVP-825」を販売する。本社所在地はペンシルベニア州ヤ―ドレ―。 Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. Optinose has offices in the U.S. and Norway. |
| 本社所在地 | 1020 Stony Hill Road Suite 300 Yardley PA 19067 USA |
| 代表者氏名 | Joseph C. Scodari ジョセフ・C.スコダリ |
| 代表者役職名 | Independent Chairman of the Board |
| 電話番号 | +1 267-364-3500 |
| 設立年月日 | 40299 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 2017年 |
| 従業員数 | 82人 |
| url | www.optinose.com |
| nasdaq_url | https://www.nasdaq.com/symbol/optn |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -84.65000 |
| 終値（lastsale） | 10.66 |
| 時価総額（marketcap） | 439411958.44 |
| 時価総額 | 時価総額（百万ドル） 469.50300 |
| 売上高 | 売上高（百万ドル） 2.13900 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 296.65100 |
| 当期純利益 | 当期純利益（百万ドル） -92.61300 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 OptiNose Inc revenues increased from $0K to $2.1M. Net loss applicable to common stockholders increased from $24.5M to $55.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Selling general and administrative increase from $6.1M to $46.2M (expense) Interest expense increase from $862K to $4.5M (expense). |
OPTNのテクニカル分析
OPTNのニュース
OptiNose, Inc. (OPTN) Q4 2022 Earnings Call Transcript 2023/03/07 19:22:05 Seeking Alpha
OptiNose, Inc. (NASDAQ:NASDAQ:OPTN) Q4 2022 Earnings Call March 7, 2023 8:00 PM ETCompany ParticipantsJonathan Neely - VP, IR and Business DevelopmentJoe Scodari - ChairmanRamy Mahmoud -…
OptiNose: Q4 Earnings Snapshot 2023/03/07 12:30:55 WTOP
YARDLEY, Pa. (AP) — YARDLEY, Pa. (AP) — OptiNose Inc. (OPTN) on Tuesday reported a loss of $15.1 million in…
OptiNose GAAP EPS of -$0.17 in-line, revenue of $20.86M beats by $0.17M 2023/03/07 12:03:46 Seeking Alpha
OptiNose press release (OPTN): Q4 GAAP EPS of -$0.17 in-line.Revenue of $20.86M (-7.3% Y/Y) beats by $0.17M.The company expects XHANCE net revenues for the full year of 2023 to…
Optinose Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Operational Highlights 2023/03/07 12:00:00 GlobeNewswire
Company reports fourth quarter and full year 2022 XHANCE net revenue of $20.9 million and $76.3 million
Earnings Preview: OptiNose 2023/03/06 17:02:27 Benzinga
OptiNose (NASDAQ: OPTN ) is set to give its latest quarterly earnings report on Tuesday, 2023-03-07. Here''s what investors need to know before the announcement. Analysts estimate that OptiNose will report an earnings per share (EPS) of $-0.17. OptiNose bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next … Full story available on Benzinga.com
Insider Alert: An Insider Just Sold OptiNose Inc Shares 2022/12/20 18:30:14 GuruFocus
Related Stocks: OPTN ,
Optinose announces departure of acting CFO Janis 2022/12/09 13:31:44 Seeking Alpha
Optinose (OPTN) has announced that Michele Janis, Acting CFO, will leave Optinose to accept a CFO opportunity at a privately-held company.Ms
Do investors need to be concerned about OptiNose Inc. (OPTN)? 2022/12/08 14:08:00 US Post News
A share of OptiNose Inc. (NASDAQ:OPTN) closed at $1.89 per share on Wednesday, up from $1.75 day before. While OptiNose Inc. has overperformed by 8.00%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, OPTN rose by 8.62%, with highs and lows ranging from $4.30 to $1.55, […]
Optinose Announces Corporate Updates and Presentation at the 34th Annual Piper Sandler Healthcare Conference 2022/11/30 12:00:00 GlobeNewswire
$50 Million from Recent Financing Extends Expected Cash Runway Beyond the Expected PDUFA Action Date for XHANCE as a Treatment for Chronic Sinusitis
Is OptiNose Inc. (OPTN) a threat to investors? 2022/11/22 15:16:00 US Post News
OptiNose Inc. (NASDAQ:OPTN) closed Monday at $1.75 per share, down from $1.90 a day earlier. While OptiNose Inc. has underperformed by -7.89%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, OPTN rose by 10.76%, with highs and lows ranging from $4.30 to $1.46, whereas the simple […]
Insider Alert: An Insider Just Sold OptiNose Inc Shares 2022/12/20 18:30:14 GuruFocus
Related Stocks: OPTN ,
Optinose announces departure of acting CFO Janis 2022/12/09 13:31:44 Seeking Alpha
Optinose (OPTN) has announced that Michele Janis, Acting CFO, will leave Optinose to accept a CFO opportunity at a privately-held company.Ms
Do investors need to be concerned about OptiNose Inc. (OPTN)? 2022/12/08 14:08:00 US Post News
A share of OptiNose Inc. (NASDAQ:OPTN) closed at $1.89 per share on Wednesday, up from $1.75 day before. While OptiNose Inc. has overperformed by 8.00%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, OPTN rose by 8.62%, with highs and lows ranging from $4.30 to $1.55, […]
Optinose Announces Corporate Updates and Presentation at the 34th Annual Piper Sandler Healthcare Conference 2022/11/30 12:00:00 GlobeNewswire
$50 Million from Recent Financing Extends Expected Cash Runway Beyond the Expected PDUFA Action Date for XHANCE as a Treatment for Chronic Sinusitis
Is OptiNose Inc. (OPTN) a threat to investors? 2022/11/22 15:16:00 US Post News
OptiNose Inc. (NASDAQ:OPTN) closed Monday at $1.75 per share, down from $1.90 a day earlier. While OptiNose Inc. has underperformed by -7.89%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, OPTN rose by 10.76%, with highs and lows ranging from $4.30 to $1.46, whereas the simple […]